Science posted an article on April 12th titled” Pandemic propels global effort to study rare vaccine side effects”. The articl...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on April 6, 2022 to discuss considerations for COVID-...

Just prior to the COVID-19 pandemic on December 2-3, 2019, the WHO Global Vaccine Safety Summit was held to celebrate the 20 yea...

Following the FDA approval of Moderna COVID-19 vaccine (Spikevax) for individuals 18 years and older on 31JAN2022, ACIP met today...

Please find a link to published recording and presentations of the ‘Unmasking safety signals in an infodemic’ webinar held on...

Following the FDA update on the Emergency Use Authorization (EUA) Fact Sheet for Pfizer-BioNTech COVID-19 vaccine on January 3rd 2...

This SPEAC deliverable summarizes Brighton Collaboration guidance on the collection, interpretation analysis and presentation of s...

This deliverable provides guidance on the collection of safety data for COVID-19 vaccine candidates. This includes a brief discuss...

As global distribution of COVID-19 vaccine expands, the Brighton Collaboration has identified a subset of adverse events of specia...

The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task For...